7th Antigen Specific Immune Tolerance Summit 2024 Hilton Boston Back Bay, Boston

The 7th Antigen-Specific Immune Tolerance Drug Development Summit returns as the definitive, industry-dedicated forum bringing you the latest discoveries, preclinical, proof-of-concept, biomarker, and clinical development on tolerogenic therapies.

Immune tolerance approaches have unprecedented potential to not only treat autoimmune diseases but to cure them; resetting the immune system is the most advantageous approach in biopharma’s arsenal to trailblaze past standard immunosuppression treatments and create a new era of transformative therapies.

With Diamyd’s phase III trial for type I diabetes, COUR, Anokion, Imcyse, Takeda, and Selecta’s phase II trials all underway, the field is on the precipice of advancing efficacious antigen-specific approaches for patients in need.

⌛ Event Dates & Venue

18 Mar - 20 Mar 2024, 9:00 am - 3:30 pm

40 Dalton Street, Massachusetts, United States, 02115

👨‍👧‍👦 Social Networks

iCal

#_REVIEWS

💸 Website & Tickets

Go to Event Website

Ticket Pricing:
Conference + 3 Workshops - Industry Pricing: USD 4197.00, Conference + 2 Workshops - Industry Pricing: USD 3797.00, Conference + 1 Workshop - Industry Pricing: USD 3398.00, Conference Only - Industry Pricing: USD 2999.00, Conference + 3 Workshops - Service Provider Pricing: USD 5097.00, Conference + 2 Workshops - Service Provider Pricing: USD 4631.00, Conference + 1 Workshop - Service Provider Pricing: USD 4166.00, Conference Only - Service Provider Pricing: USD 3699.00, Conference + 3 Workshops - Academic Pricing: USD 3597.00, Conference Only - Academic Pricing: USD 2599.00

Buy Tickets